Skye Bioscience, Inc. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Skye Bioscience, Inc. (SKYE) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$11.74 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-10
- Skye Bioscience, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for the quarter ending 2014-01-31 was $100.00.
- Skye Bioscience, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$11.74M.
- Skye Bioscience, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$5.58M.
- Skye Bioscience, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$7.90M.
- Skye Bioscience, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$4.09M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 3 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 6 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 9 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$11.74M 10-K · filed 2026-03-10 | ||||
| 2024-12-31 | -$5.58M 10-K · filed 2026-03-10 | ||||
| 2023-12-31 | -$7.90M 10-K · filed 2025-03-20 | ||||
| 2022-12-31 | -$4.09M 10-K · filed 2024-03-22 | ||||
| 2021-12-31 | -$1.79M 10-K · filed 2023-03-31 | ||||
| 2020-12-31 | -$1.38M 10-K · filed 2022-03-28 | ||||
| 2019-12-31 | $221.22K 10-K · filed 2021-03-02 | ||||
| 2018-12-31 | -$4.03M 10-K · filed 2020-03-23 | ||||
| 2017-12-31 | -$1.08M 10-K · filed 2019-03-14 | ||||
| 2016-12-31 | -$1.11M 10-K · filed 2018-03-19 | ||||
| 2015-12-31 | -$1.69M 10-K · filed 2017-03-10 | ||||
| 2014-07-31 | $760.00 10-Q · filed 2014-09-15 | ||||
| 2014-04-30 | $3.40K 10-Q · filed 2014-06-05 | ||||
| 2014-01-31 | $100.00 10-Q · filed 2014-03-17 | ||||
| 2013-10-31 | $1.30K 10-Q · filed 2014-09-15 | -$1.30K 10-K · filed 2014-01-27 | |||
| 2013-07-31 | $588.00 10-Q · filed 2013-09-16 | ||||
| 2013-04-30 | $1.14K 10-Q · filed 2013-06-27 | ||||
| 2012-10-31 | $1.62K 10-K · filed 2014-01-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |